Determinantes sociales que influyen en el acceso en Chile al Plan GES, según CASEN 2017 / Social determinants of access to the explicit guarantees health program implemented in Chile
Rev. méd. Chile
;
150(1): 70-77, ene. 2022. tab
Article
in Spanish
| LILACS
| ID: biblio-1389620
ABSTRACT
BACKGROUND:
In Chile, an eventual implementation of a plan with universal health coverage is a challenge. The already implemented explicit health guarantees plan (GES) could be a benchmark. For this reason, it is important to obtain information about the results of its implementation.AIM:
To identify the social determinants of health that influence the access to GES. MATERIAL ANDMETHODS:
The National Socioeconomic Characterization Survey performed in 2017 was used as a data source. The beneficiaries of 20 diseases covered by GES and inquired in the survey were considered for the present study.RESULTS:
People with the higher probability of access to GES plan belong to the lowest income quintiles, are nationals, live in the central-southern metropolitan Santiago, have lower education, have a public health insurance program (FONASA) and are aged mostly over 60 years. The diseases with the highest probability of access to the program are primary arterial hypertension, type 1 and type 2 diabetes mellitus, acute myocardial infarction, moderate and severe bronchial asthma, breast cancer, colon cancer, and bipolar disorder.CONCLUSIONS:
The access probability to the GES program is in line with the epidemiological profile of the Chilean population, and with a greater social vulnerability.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Social Determinants of Health
/
Health Services Accessibility
/
National Health Programs
Type of study:
Prognostic study
Limits:
Aged
/
Humans
Country/Region as subject:
South America
/
Chile
Language:
Spanish
Journal:
Rev. méd. Chile
Journal subject:
Medicine
Year:
2022
Type:
Article
Affiliation country:
Chile
Institution/Affiliation country:
Universidad de Talca/CL
/
Universidad de la Frontera/CL
Similar
MEDLINE
...
LILACS
LIS